NO881745L - Fremgangsmaate for fremstilling av 17beta-(cyclopropyloxy)androst-5-en-3beta-ol og beslektede forbindelser. - Google Patents

Fremgangsmaate for fremstilling av 17beta-(cyclopropyloxy)androst-5-en-3beta-ol og beslektede forbindelser.

Info

Publication number
NO881745L
NO881745L NO881745A NO881745A NO881745L NO 881745 L NO881745 L NO 881745L NO 881745 A NO881745 A NO 881745A NO 881745 A NO881745 A NO 881745A NO 881745 L NO881745 L NO 881745L
Authority
NO
Norway
Prior art keywords
androst
cyclopropyloxy
related compounds
17beta
oles
Prior art date
Application number
NO881745A
Other languages
English (en)
Other versions
NO881745D0 (no
NO168892B (no
NO168892C (no
Inventor
Michael R Angelastro
Thomas R Blohm
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO881745D0 publication Critical patent/NO881745D0/no
Publication of NO881745L publication Critical patent/NO881745L/no
Publication of NO168892B publication Critical patent/NO168892B/no
Publication of NO168892C publication Critical patent/NO168892C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO881745A 1987-04-22 1988-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropyloxy)androst-5-en-3beta-ol-derivater NO168892C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/041,170 US4891367A (en) 1987-04-22 1987-04-22 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Publications (4)

Publication Number Publication Date
NO881745D0 NO881745D0 (no) 1988-04-21
NO881745L true NO881745L (no) 1988-10-24
NO168892B NO168892B (no) 1992-01-06
NO168892C NO168892C (no) 1992-04-15

Family

ID=21915121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881745A NO168892C (no) 1987-04-22 1988-04-21 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 17beta-(cyclopropyloxy)androst-5-en-3beta-ol-derivater

Country Status (20)

Country Link
US (1) US4891367A (no)
EP (1) EP0291717B1 (no)
JP (1) JP2593685B2 (no)
KR (1) KR960015036B1 (no)
CN (1) CN1024279C (no)
AT (1) ATE78487T1 (no)
AU (1) AU605575B2 (no)
CA (1) CA1309088C (no)
DE (1) DE3872938T2 (no)
DK (1) DK167766B1 (no)
ES (1) ES2051787T3 (no)
FI (1) FI87791C (no)
GR (1) GR3005370T3 (no)
HU (1) HU198508B (no)
IL (1) IL86140A (no)
NO (1) NO168892C (no)
NZ (1) NZ224287A (no)
PH (1) PH23863A (no)
PT (1) PT87293B (no)
ZA (1) ZA882715B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224288A (en) * 1987-04-22 1989-12-21 Merrell Dow Pharma 17b-(cyclopropylamino)androst-5-en-3b-ol and related compounds and methods using these for treatment of non-humans
US4954488A (en) * 1989-06-14 1990-09-04 Merrell Dow Pharmaceuticals Inc. Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
US4966897A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5051534A (en) * 1990-03-22 1991-09-24 Merrell Dow Pharmaceuticals Inc. Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
US5102915A (en) * 1990-03-22 1992-04-07 Merrell Dow Pharmaceuticals Inc. Cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
WO2003039250A2 (en) * 2001-11-08 2003-05-15 Colorado State University Research Foundation Termite feeding stimulant and method for using same
EP2155204B1 (en) * 2007-06-15 2016-08-17 Research Triangle Institute Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135744A (en) * 1961-04-12 1964-06-02 Vismara Francesco Spa Cycloalkenyl ethers of 17 beta-hydroxy androstanes
CH471103A (de) * 1962-02-28 1969-04-15 Warner Lambert Pharmaceutical Verfahren zur Herstellung neuer (1'-Alkoxy)-alkyl- und cycloalkyläther von 17B-Hydroxysteroiden
US3475464A (en) * 1966-11-07 1969-10-28 Syntex Corp Process for the preparation of steroids and novel intermediates thereof
US3732209A (en) * 1971-03-15 1973-05-08 Hoffmann La Roche Novel 17beta-oxygenated cyclopropa(16alpha,17alpha)steroids
US3763146A (en) * 1972-02-03 1973-10-02 Syntex Corp Novel 17beta(tetrahydropyran-4-yloxy)steroids
US4139617A (en) * 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4420428A (en) * 1982-12-27 1983-12-13 E. R. Squibb & Sons, Inc. 16-Ketoandrostene-17-dithioketals
US4427592A (en) * 1983-01-31 1984-01-24 E. R. Squibb & Sons, Inc. Androstene-17-dithioketals
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
NZ224288A (en) * 1987-04-22 1989-12-21 Merrell Dow Pharma 17b-(cyclopropylamino)androst-5-en-3b-ol and related compounds and methods using these for treatment of non-humans

Also Published As

Publication number Publication date
FI881878A0 (fi) 1988-04-21
FI881878A (fi) 1988-10-23
AU1472088A (en) 1988-10-27
DK217488A (da) 1988-10-23
GR3005370T3 (no) 1993-05-24
HUT47305A (en) 1989-02-28
HU198508B (en) 1989-10-30
ES2051787T3 (es) 1994-07-01
FI87791B (fi) 1992-11-13
DE3872938T2 (de) 1993-01-07
CN1024279C (zh) 1994-04-20
US4891367A (en) 1990-01-02
JP2593685B2 (ja) 1997-03-26
EP0291717B1 (en) 1992-07-22
DK167766B1 (da) 1993-12-13
ATE78487T1 (de) 1992-08-15
FI87791C (fi) 1993-02-25
PT87293A (pt) 1988-05-01
NO881745D0 (no) 1988-04-21
NZ224287A (en) 1989-11-28
CA1309088C (en) 1992-10-20
IL86140A (en) 1993-02-21
ZA882715B (en) 1988-10-17
JPS63284194A (ja) 1988-11-21
KR880012634A (ko) 1988-11-28
DK217488D0 (da) 1988-04-21
PT87293B (pt) 1992-08-31
EP0291717A1 (en) 1988-11-23
NO168892B (no) 1992-01-06
CN88102175A (zh) 1988-11-16
IL86140A0 (en) 1988-11-15
AU605575B2 (en) 1991-01-17
NO168892C (no) 1992-04-15
PH23863A (en) 1989-11-23
KR960015036B1 (ko) 1996-10-24
DE3872938D1 (de) 1992-08-27

Similar Documents

Publication Publication Date Title
ZA906307B (en) 4-substituted 18beta-(cyclopropyloxy)androst-5-en-3beta-ol and related compounds useful as c17-20lyase inhibitors
NO881746L (no) Fremgangsmaate for fremstilling av 17beta-(cyclopropylamino)androst-5-en-3beta-ol og beslektede forbindelser.
NO881745D0 (no) Fremgangsmaate for fremstilling av 17beta-(cyclopropyloxy)androst-5-en-3beta-ol og beslektede forbindelser.
NO903564L (no) Fremgangsmaate for fremstilling av 4-substituerte 17beta-(cyklopropylamino)androst-5-en-3beta-ol-derivater.
FR2569068B1 (fr) Appareil de decodage de codes d'image obtenus par un processus de compression
HUT47616A (en) Curable rubber mixture comprising substituted n-trichloro-methyl-thiohydantoins and bis(2,4-diamino-s-triazin-6-yl)-oligosulfides and process for producing same
SU657813A1 (ru) Аппарат дл лечени переломов костей
ES2024632B3 (es) Caseta de separacion.
IT1245737B (it) Trialchilsilil tetrafluoroetanfosfonati e procedimento per la loro preparazione
BG36349A3 (en) Method for preparing s- (tertiary alkyl)- ethylthiophosphonates
IT1244888B (it) Procedimento per la sintesi di composti aromatici fluorurati
PL254252A2 (en) Method of obtaining novel 2,3,3-trimethylcyclopentyl vinyl ether